logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
王震 封面图

王震 (Zhen Wang)

college of stomatologypostdoctoral researcher
H指数:4
被引数:99

个人简介

"During Feb 2022-June 2024, I was a postdoctoral researcher in the School of Data Science at CUHK Shenzhen, under the supervision of Zizhuo Wang. I received my Ph.D. in the School of Information Management and Engineering from Shanghai University of Finance and Economics, China, where I was very fortunate to be advised by Simai He. Prior to that, I received my B.Eng. from Sichuan University, China. My research interests lie in distributionally robust optimization and its applications in operations management. My most recent work focuses on: Distributionally Robust Optimization and Moment Problem; Mechanism Design and Public Goods Allocation; Pricing and Revenue Management\n教授课程\n随机决策分析；优化理论与算法"

教育背景

暂无内容

工作经历

  • 2022.02 – 2024.06

    School of Data Science at CUHK Shenzhen

    postdoctoral researcher

荣誉奖项

  1. The second place in the 2023 POMS-China Best Student Paper Award（2023）
  2. Honorable mentions in the 2025 POMS-China Best Student Paper Award（2025）
  3. The third place in the 2025 POMS-China Best Student Paper Award（2025）
  4. Honorable mentions in the 2024 ISCOM Best Student Paper Award（2025）
  5. The first place in the 2025 POMS-China Best Student Paper Award（2025）
Comparison of the effects of 19 exercise interventions on symptoms, pain, balance, and muscular strength in patients with chemotherapy-induced peripheral neuropathy: A systematic review and network meta-analysis

比较19种运动干预措施对化疗诱导性周围神经病变患者症状、疼痛、平衡及肌肉力量影响的系统评价和网络荟萃分析

INTERNATIONAL JOURNAL OF NURSING STUDIES
IF7.1
2025-04-010
PRE
Wang, Zhenzhen; Zhao, Bingxin; Li, Yao; Jing, Jiamei; Suo, Lina; Zhang, Guozeng
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
CELL REPORTS
IF6.9
2024-08-010
OAAI
Li, Yang-Si; Lai, Wen-Pu; Yin, Kai; Zheng, Mei-Mei; Tu, Hai-Yan; Guo, Wei-Bang; Li, Liang; Lin, Shou-Heng; Wang, Zhen; Zeng, Lu; Chen, Zhi-Hong; Zhou, Qing; Zhang, Xu-Chao; Yang, Jin-Ji; Zhong, Wen-Zhao; Yang, Xue-Ning; Wang, Bin-Chao; Pan, Yi; Chen, Hua-Jun; Xiao, Fa-Man; Sun, Hao; Sun, Yue-Li; Bai, Xiao-Yan; Ke, E. -e.; Lin, Jia-Xin; Liu, Si-Yang Maggie; Li, Yangqiu; Luo, Oscar Junhong; Wu, Yi-Long
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

未经治疗的晚期非小细胞肺癌患者sintilimab与pembrolizumab联合或不联合铂类双重化疗的PD-L1表达指南 (CTONG1901): 一项2期随机对照试验

SCIENCE BULLETIN
IF21.1
2024-02-016
OAAI
Liu, Si-Yang Maggie; Huang, Jie; Deng, Jia-Yi; Xu, Chong-Rui; Yan, Hong-Hong; Yang, Ming-Yi; Li, Yang-Si; Ke, E-e; Zheng, Ming-Ying; Wang, Zhen; Lin, Jia-Xin; Gan, Bin; Zhang, Xu-Chao; Chen, Hua-Jun; Wang, Bin-Chao; Tu, Hai-Yan; Yang, Jin-Ji; Zhong, Wen-Zhao; Li, Yangqiu; Zhou, Qing; Wu, Yi-Long
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
ECLINICALMEDICINE
IF10
2023-10-014
OAAI
Liu, Si-Yang Maggie; Dong, Xiao-Rong; Wang, Zhen; Du, Yingying; Cui, Jiu-Wei; Chu, Qian; Xu, Bing-Fei; Zheng, Ming-Ying; Deng, Jia-Yi; Lu, Chang; Wei, Xue-Wu; Li, Yang-Si; Zheng, Mei-Mei; Yang, Ming-Yi; Huang, Jie; Li, Anna; Bai, Xiao-Yan; Sun, Yue-Li; Xu, Chong-Rui; Wang, Bin-Chao; Chen, Hua-Jun; Yang, Jin-Ji; Yan, Hong-Hong; Zhong, Wen-Zhao; Zhou, Qing; Wu, Yi-Long

研究方向

分布鲁棒优化矩问题机制设计公共品分配Pricing and Revenue Management
Y
Yi‐Long Wu
H 指数:135论文数:2,242被引数:11.2万
周
周清
H 指数:58论文数:532被引数:1.6万
H
Hua‐Jun Chen
H 指数:33论文数:204被引数:4,640
C
Chong‐Rui Xu
H 指数:36论文数:284被引数:7,324
H
Hai‐Yan Tu
H 指数:36论文数:292被引数:6,484
H
Hong‐Hong Yan
H 指数:40论文数:248被引数:7,463
J
Jin‐Ji Yang
H 指数:50论文数:296被引数:8,881
Y
Yang-Si Li
H 指数:14论文数:50被引数:883
X
Xu‐Chao Zhang
H 指数:49论文数:299被引数:9,074
B
Bin-Chao Wang
H 指数:17论文数:73被引数:1,380